The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The role of DAT-SPECT in movement disorders
Abstract
Dopamine transporter (DAT) imaging is a sensitive method to detect presynaptic dopamine neuronal dysfunction, which is a hallmark of neurodegenerative parkinsonism. DAT imaging can therefore assist the differentiation between conditions with and without presynaptic dopaminergic deficit. Diagnosis of Parkinson disease or tremor disorders can be achieved with high degrees of accuracy in cases with full expression of classical clinical features; however, diagnosis can be difficult, since there is a substantial clinical overlap especially in monosymptomatic tremor (dystonic tremor, essential tremor, Parkinson tremor). The use of DAT-SPECT can prove or excludes with high sensitivity nigrostriatal dysfunction in those cases and facilitates early and accurate diagnosis. Furthermore, a normal DAT-SPECT is helpful in supporting a diagnosis of drug-induced-, psychogenic- and vascular parkinsonism by excluding underlying true nigrostriatal dysfunction. This review addresses the value of DAT-SPECT and its impact on diagnostic accuracy in movement disorders presenting with tremor and/or parkinsonism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Levodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10609 · Cited by 829
Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease
Hughes, A. J., Daniel, S. E., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.57.8.1497 · Cited by 807
McKeith, I., O'Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J., Padovani, A., Giubbini, R., Bonuccelli, U., Volterrani, D., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70057-1 · Cited by 716
Parkinson Study Group (2002) · JAMA · doi:10.1001/jama.287.13.1653 · Cited by 711
Benamer, H. T. S., Patterson, J., Grosset, D. G., Booij, J., de Bruin, K., van Royen, E., Speelman, J. D., Horstink, M. H. I. M., Sips, H. J. W. A., Dierckx, R. A., et al. (2000) · Movement Disorders · doi:10.1002/1531-8257(200005)15:3<503::aid-mds1013>3.0.co;2-v · Cited by 707
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Farde, L. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250087012 · Cited by 692
The dopamine transporter: immunochemical characterization and localization in brain
Ciliax, B., Heilman, C., Demchyshyn, L., Pristupa, Z., Ince, E., Hersch, S., Niznik, H., & Levey, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01714.1995 · Cited by 589
Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A. R., Bioulac, B., Brotchie, J. M., & Gross, C. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06853.2001 · Cited by 483
Seibyl, J. P., Marchek, K. L., Quinlan, D., Sheff, K., Zoghbi, S., Zea‐Ponce, Y., Baldwin, R. M., Fussell, B., Smith, E. O., Charney, D. S., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380407 · Cited by 467
Stiasny-Kolster, K. (2004) · Brain · doi:10.1093/brain/awh322 · Cited by 430
FDG PET in the differential diagnosis of parkinsonian disorders
Eckert, T., Barnes, A., Dhawan, V., Frucht, S., Gordon, M. F., Feigin, A. S., & Eidelberg, D. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.03.012 · Cited by 419
A study of hereditary essential tremor
Bain, P. G., Findley, L. J., Thompson, P. D., Gresty, M. A., Rothwell, J. C., Harding, A. E., & Marsden, C. D. (1994) · Brain · doi:10.1093/brain/117.4.805 · Cited by 392
Zijlmans, J. C. M., Daniel, S. E., Hughes, A. J., Révész, T., & Lees, A. J. (2004) · Movement Disorders · doi:10.1002/mds.20083 · Cited by 383
Essential tremor: Clinical correlates in 350 patients
Lou, J.-S., & Jankovic, J. (1991) · Neurology · doi:10.1212/wnl.41.2_part_1.234 · Cited by 375
An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1996) · Brain · doi:10.1093/brain/119.2.585 · Cited by 366
Marek, K. L., Seibyl, J. P., Zoghbi, S. S., Zea-Ponce, Y., Baldwin, R. M., Fussell, B., Charney, D. S., van Dyck, C., Hoffer, P. B., & Innis, R. B. (1996) · Neurology · doi:10.1212/wnl.46.1.231 · Cited by 365
Laruelle, M., Baldwin, R. M., Malison, R. T., Zea‐Ponce, Y., Zoghbi, S. S., Al‐Tikeriti, M. S., Sybirska, E. H., Zimmermann, R. C., Wisniewski, G., Neumeyer, J. L., et al. (1993) · Synapse · doi:10.1002/syn.890130402 · Cited by 351
O'Brien, J. T., Colloby, S., Fenwick, J., Williams, E. D., Firbank, M., Burn, D., Aarsland, D., & McKeith, I. G. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.919 · Cited by 334
Piggott, M. A., Marshall, E. F., Thomas, N., Lloyd, S., Court, J. A., Jaros, E., Burn, D., Johnson, M., Perry, R. H., McKeith, I. G., et al. (1999) · Brain · doi:10.1093/brain/122.8.1449 · Cited by 330
Psychogenic movement disorders: frequency, clinical profile, and characteristics.
Factor, S. A., Podskalny, G. D., & Molho, E. S. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.4.406 · Cited by 310
Catafau, A. M., & Tolosa, E. (2004) · Movement Disorders · doi:10.1002/mds.20112 · Cited by 290
Self-citationWalker, Z., Jaros, E., Walker, R. W. H., Lee, L., Costa, D. C., Livingston, G., Ince, P. G., Perry, R., McKeith, I., & Katona, C. L. E. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.110122 · Cited by 279
Booij, J., Speelman, J. D., Horstink, M. W. I. M., & Wolters, E. C. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590000460 · Cited by 264
Adams, J. R., van Netten, H., Schulzer, M., Mak, E., Mckenzie, J., Strongosky, A., Sossi, V., Ruth, T. J., Lee, C. S., Farrer, M., et al. (2005) · Brain · doi:10.1093/brain/awh607 · Cited by 262
Schneider, S. A., Edwards, M. J., Mir, P., Cordivari, C., Hooker, J., Dickson, J., Quinn, N., & Bhatia, K. P. (2007) · Movement Disorders · doi:10.1002/mds.21685 · Cited by 247
Self-citationSommer, U., Hummel, T., Cormann, K., Mueller, A., Frasnelli, J., Kropp, J., & Reichmann, H. (2004) · Movement Disorders · doi:10.1002/mds.20141 · Cited by 244
Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?
Pirker, W. (2003) · Movement Disorders · doi:10.1002/mds.10579 · Cited by 232
Pirker, W., Djamshidian, S., Asenbaum, S., Gerschlager, W., Tribl, G., Hoffmann, M., & Brücke, T. (2002) · Movement Disorders · doi:10.1002/mds.1265 · Cited by 213
Marshall, V. L., Reininger, C. B., Marquardt, M., Patterson, J., Hadley, D. M., Oertel, W. H., Benamer, H. T. S., Kemp, P., Burn, D., Tolosa, E., et al. (2009) · Movement Disorders · doi:10.1002/mds.22108 · Cited by 211
Self-citationPirker, W., Asenbaum, S., Bencsits, G., Prayer, D., Gerschlager, W., Deecke, L., & Br�cke, T. (2000) · Movement Disorders · doi:10.1002/1531-8257(200011)15:6<1158::aid-mds1015>3.0.co;2-0 · Cited by 206
Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A., Brooks, D. J., & Piccini, P. (2002) · Annals of Neurology · doi:10.1002/ana.10417 · Cited by 199
Natural history and syndromic associations of orthostatic tremor: A review of 41 patients
Gerschlager, W., Münchau, A., Katzenschlager, R., Brown, P., Rothwell, J. C., Quinn, N., Lees, A. J., & Bhatia, K. P. (2004) · Movement Disorders · doi:10.1002/mds.20132 · Cited by 193
Self-citationHedrich, K., Djarmati, A., Schäfer, N., Hering, R., Wellenbrock, C., Weiss, P. H., Hilker, R., Vieregge, P., Ozelius, L. J., Heutink, P., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000113022.51739.88 · Cited by 185
SAWLE, G. V., BROOKS, D. J., MARSDEN, C. D., & FRACKOWIAK, R. S. J. (1991) · Brain · doi:10.1093/brain/114.1.541 · Cited by 178
Essential tremor: an overdiagnosed condition?
Schrag, A. E., Münchau, A. M., Bhatia, K. P., Quinn, N. P., & MARSDEN, C. D. (2000) · Journal of Neurology · doi:10.1007/s004150070053 · Cited by 170
Self-citation[ 123 I]β-CIT and SPECT in essential tremor and Parkinson's disease
Asenbaum, S., Pirker, W., Angelberger, P., Bencsits, G., Pruckmayer, M., & Brücke, T. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050124 · Cited by 167
Varrone, A., Marek, K. L., Jennings, D., Innis, R. B., & Seibyl, J. P. (2001) · Movement Disorders · doi:10.1002/mds.1256 · Cited by 166
Benamer, H. T. S., Oertel, W. H., Patterson, J., Hadley, D. M., Pogarell, O. M., Höffken, H., Gerstner, A., & Grosset, D. G. (2003) · Movement Disorders · doi:10.1002/mds.10482 · Cited by 165
Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study
Khan, N. L. (2002) · Brain · doi:10.1093/brain/awf237 · Cited by 160
Reversible Drug-Induced Parkinsonism
Rajput, A. H. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510220042009 · Cited by 145
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
Bonanni, L., Thomas, A., & ONOFRJ, M. C. (2006) · Neurology · doi:10.1212/01.wnl.0000224698.67660.45 · Cited by 127
Abi‐Dargham, A., Gandelman, M. S., DeErausquin, G. A., Zea‐Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Laruelle, M., Charney, D. S., Hoffer, P. B., Neumeyer, J. L., et al. (1996) · PubMed · Cited by 125
Levodopa and the progression of Parkinson’s disease
Morgan, J. C., & Sethi, K. D. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0069-1 · Cited by 123
[ 123 I]β‐CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease
Gerschlager, W., Bencsits, G., Pirker, W., Bloem, B. R., Asenbaum, S., Prayer, D., Zijlmans, J. C. M., Hoffmann, M., & Brücke, T. (2002) · Movement Disorders · doi:10.1002/mds.10092 · Cited by 116
[123I] FP‐CIT spect study in vascular parkinsonism and Parkinson's disease
Zijlmans, J. C. M., Evans, A. H., Fontes, F., Katzenschlager, R., Gacinovic, S., Lees, A. J., & Costa, D. C. (2007) · Movement Disorders · doi:10.1002/mds.21479 · Cited by 114
Jeon, B. S., Jeong, J., Park, S. S., Kim, J., Chang, Y., Song, H., Kim, K., Yoon, K., Lee, M. C., & Lee, S. (1998) · Annals of Neurology · doi:10.1002/ana.410430614 · Cited by 114
Chaudhuri, К. R., Buxton-Thomas, M., Dhawan, V., Peng, R., Meilak, C., & Brooks, D. J. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.046292 · Cited by 109
Lang, A. E., Koller, W. C., & Fahn, S. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540320078015 · Cited by 106
Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
Tzen, K., Lu, C., Yen, T. C., Wey, S., & Ting, G. (2001) · PubMed · Cited by 105
Rating scale for psychogenic movement disorders: Scale development and clinimetric testing
Hinson, V. K., Cubo, E., Comella, C. L., Goetz, C. G., & Leurgans, S. E. (2005) · Movement Disorders · doi:10.1002/mds.20650 · Cited by 105
DAT imaging in drug-induced and psychogenic parkinsonism
TOLOSA, E. S., Coelho, M. M., & Gallardo, M. (2003) · Movement Disorders · doi:10.1002/mds.10575 · Cited by 104
Self-citationThe L-dopa response in vascular parkinsonism
Zijlmans, J. C. M. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.018309 · Cited by 99
Lorberboym, M., Djaldetti, R., Melamed, E., Sadeh, M., & Lampl, Y. (2004) · PubMed · Cited by 94
Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT
Lavalaye, J., LINSZEN, D. H., Booij, J., Dingemans, P. M. A. J., Reneman, L., Habraken, J. B. A., Gersons, B. P. R., & van Royen, E. A. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00023-2 · Cited by 88
Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration
Klaffke, S., Kuhn, A. A., Plotkin, M., Amthauer, H., Harnack, D., Felix, R., & Kupsch, A. (2006) · Movement Disorders · doi:10.1002/mds.21004 · Cited by 87
[123I]‐FP‐CIT‐SPECT demonstrates dopaminergic deficit in orthostatic tremor
Katzenschlager, R., Costa, D. C., Gerschlager, W., O’Sullivan, J. D., Zijlmans, J. C. M., Gacinovic, S., Pirker, W., Wills, A. J., Bhatia, K. P., Lees, A. J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10475 · Cited by 84
Self-citationA multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism
Quinn, N. P. (2001) · Neurology · doi:10.1212/wnl.57.4.746-a · Cited by 83
PET studies of parkinsonism associated with mutation in the α-synuclein gene
Samii, A., Markopoulou, K., Wszołek, Z. K., Sossi, V., Dobko, T., Mak, E., Calne, D. B., & Stoessl, A. J. (1999) · Neurology · doi:10.1212/wnl.53.9.2097 · Cited by 60
123I‐Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism
Gaig, C., Martı́, M. J., TOLOSA, E. S., Valldeoriola, F., Paredes, P., Lomeña, F. J., & Nakamae, F. (2006) · Movement Disorders · doi:10.1002/mds.21062 · Cited by 59
Self-citationStriatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease
Ransmayr, G. N., Seppi, K., Donnemiller, E., Luginger, E., Marksteiner, J., Riccabona, G., Poewe, W. H., & Wenning, G. K. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100571 · Cited by 59
Rinne, J. O., Burn, D. J., Mathias, C. J., Quinn, N. P., MARSDEN, C. D., & Brooks, D. J. (1995) · Annals of Neurology · doi:10.1002/ana.410370505 · Cited by 55
Imaging of dopaminergic dysfunction with [ 123 I]FP-CIT SPECT in early-onset parkin disease
Varrone, A., Pellecchia, M. T., Amboni, M., Sansone, V., Salvatore, E., Ghezzi, D., Garavaglia, B., Brice, A., Brunetti, A., Bonavita, V., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000145765.19094.94 · Cited by 53
Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
Yen, T. C., Tzen, K., Chen, M. C., Chou, Y. W., Chen, R. S., Chen, C. J., Wey, S., Ting, G., & Lu, C. S. (2002) · PubMed · Cited by 47
Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson’s syndrome
Kessler, K. R., Hamscho, N., Morales, B., Menzel, C., Barrero, F. J., Vives, F., Gispert, S., & Auburger, G. W. J. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0281-9 · Cited by 40
Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers
Ceravolo, R., Antonini, A., Volterrani, D., Rossi, C., Goldwurm, S., Di Maria, E., Kiferle, L., Bonuccelli, U., & Murri, L. (2005) · Neurology · doi:10.1212/01.wnl.0000188821.51055.52 · Cited by 33
Neuroleptics and Dopamine Transporters
Reader, T. A., Ase, A. R., Huang, N., Hébert, C., & van Gelder, N. M. (1998) · Neurochemical Research · doi:10.1023/a:1022405621365 · Cited by 27
Correlation of Parkinson's disease severity and duration with123I-FP-CIT SPECT striatal uptake
Benamer, H. T. S., Patterson, J., Wyper, D. J., Hadley, D. M., Macphee, G. J. A., & Grosset, D. G. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4<692::aid-mds1014>3.0.co;2-v
Cited by
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Erkkinen, M. G., Kim, M.-O., & Geschwind, M. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033118 · Cited by 1,124
Clinical Approach to Parkinson's Disease: Features, Diagnosis, and Principles of Management
Massano, J., & Bhatia, K. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008870 · Cited by 422
Self-citationShin, H.-W., & Chung, S. J. (2012) · Journal of Clinical Neurology · doi:10.3988/jcn.2012.8.1.15 · Cited by 354
Sulzer, D., Cassidy, C., Horga, G., Kang, U. J., Fahn, S., Casella, L., Pezzoli, G., Langley, J., Hu, X. P., Zucca, F. A., et al. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0047-3 · Cited by 270
Systematic clinical approach for diagnosing upper limb tremor
Wardt, J. V. D., van der Stouwe, A. M. M., Dirkx, M., Elting, J. W. J., Post, B., Tijssen, M. A., & Helmich, R. C. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322676 · Cited by 72
Metadata
- Authors
- Kagi, G., Bhatia, K. P., & Tolosa, E.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2009-12-17
- Volume
- 81
- Issue
- 1
- Pages
- 5-12
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2165294823
- Cited by
- 311
- References
- 70
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.